Literature DB >> 9569236

Changes in expression of 15-lipoxygenase and prostaglandin-H synthase during differentiation of human tracheobronchial epithelial cells.

E M Hill1, T Eling, P Nettesheim.   

Abstract

The purpose of our studies was to examine differentiation-dependent expression of 15-lipoxygenase (15-LO) and prostaglandin H synthase (PGHS) isoforms in cultured normal human tracheobronchial epithelial cells. In the presence of retinoic acid (RA) the cultures differentiated into a mucociliary epithelium. When cultured in RA-depleted media, the cultures differentiated into a squamous epithelium. In the absence of RA the cultures did not express 15-LO or either of the PGHS isoforms. The PGHS-1 isoform was not expressed in RA-sufficient cultures, but both PGHS-2 messenger RNA (mRNA) and protein were strongly expressed, and prostaglandin E2 (PGE2) was produced during the predifferentiation phase. No PGHS-2 expression or PGE2 could be detected in fully differentiated mucociliary cultures. 15-LO showed the opposite expression pattern: neither mRNA nor protein were detected during the predifferentiation stage, but both were strongly expressed once mucous differentiation had occurred. Cytosolic phospholipase A2 protein was expressed throughout all stages of growth and differentiation. The cultures generated no 15-LO metabolites when incubated with 10 microM to 50 microM arachidonic acid (AA) and stimulated with ionophore. However, lysates prepared from such cultures generated 15-hydroxyeicosatetraenoic acid (15-HETE) and 12-HETE from AA, indicating that the cells contained active enzyme. When cultures expressing 15-LO protein were incubated with 10 microM linoleic acid (LA) instead of AA, and were stimulated with ionophore, they generated 13-hydroxy-9,11-octadecadienoic acid. LA rather than AA appeared to be the preferred substrate for the 15-LO enzyme. Our studies indicated that the expression of 15-LO and PGHS-2 is differentiation dependent in airway epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9569236     DOI: 10.1165/ajrcmb.18.5.2985

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  7 in total

Review 1.  15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in?

Authors:  Sun Il Lee; Xiangsheng Zuo; Imad Shureiqi
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

Review 2.  The role of 15-LOX-1 in colitis and colitis-associated colorectal cancer.

Authors:  Fei Mao; Mei Wang; Juanjuan Wang; Wen-Rong Xu
Journal:  Inflamm Res       Date:  2015-07-21       Impact factor: 4.575

3.  The transcription factor GATA-6 is overexpressed in vivo and contributes to silencing 15-LOX-1 in vitro in human colon cancer.

Authors:  Imad Shureiqi; Xiangsheng Zuo; Russell Broaddus; Yuanqing Wu; Baoxiang Guan; Jeffrey S Morris; Scott M Lippman
Journal:  FASEB J       Date:  2006-12-13       Impact factor: 5.191

Review 4.  Eicosanoid profiling in colon cancer: emergence of a pattern.

Authors:  Xiangsheng Zuo; Imad Shureiqi
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-09-01       Impact factor: 3.072

5.  Chromatin modification requirements for 15-lipoxygenase-1 transcriptional reactivation in colon cancer cells.

Authors:  Xiangsheng Zuo; Jeffrey S Morris; Imad Shureiqi
Journal:  J Biol Chem       Date:  2008-09-17       Impact factor: 5.157

6.  Asthmatics exhibit altered oxylipin profiles compared to healthy individuals after subway air exposure.

Authors:  Susanna L Lundström; Bettina Levänen; Malin Nording; Anna Klepczynska-Nyström; Magnus Sköld; Jesper Z Haeggström; Johan Grunewald; Magnus Svartengren; Bruce D Hammock; Britt-Marie Larsson; Anders Eklund; Åsa M Wheelock; Craig E Wheelock
Journal:  PLoS One       Date:  2011-08-29       Impact factor: 3.240

7.  Retinoic acid improves morphology of cultured peritoneal mesothelial cells from patients undergoing dialysis.

Authors:  Carmen Retana; Elsa I Sanchez; Sirenia Gonzalez; Alejandro Perez-Lopez; Armando Cruz; Jesus Lagunas-Munoz; Carmen Alfaro-Cruz; Socorro Vital-Flores; José L Reyes
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.